Immunohistochemical Analysis of Human Equilibrative Nucleoside Transporter-1 (hENT1) Predicts Survival in Resected Pancreatic Cancer Patients Treated with Adjuvant Gemcitabine Monotherapy

Author： Morinaga Soichiro   Nakamura Yoshiyasu   Watanabe Takuo   Mikayama Hiroshi   Tamagawa Hiroshi   Yamamoto Naoto   Shiozawa Manabu   Akaike Makoto   Ohkawa Shinnichi   Kameda Yoichi   Miyagi Yohei  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.19, Iss.3, 2012-07, pp. : 558-564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Combined Analysis of Dihydropyrimidine Dehydrogenase and Human Equilibrative Nucleoside Transporter 1 Expression Predicts Survival of Pancreatic Carcinoma Patients Treated with Adjuvant Gemcitabine Plus S-1 Chemotherapy after Surgical Resection

By Kondo Naru   Murakami Yoshiaki   Uemura Kenichiro   Sudo Takeshi   Hashimoto Yasushi   Nakashima Akira   Sueda Taijiro  

Annals of Surgical Oncology, Vol. 19, Iss. 3, 2012-07 ,pp. : 646-655

Springer Publishing Company

Access to resources Recommend Favorite

Impact of dihydropyrimidine dehydrogenase and γ-glutamyl hydrolase on the outcomes of patients treated with gemcitabine or S-1 as adjuvant chemotherapy for advanced pancreatic cancer

By                

Experimental and Therapeutic Medicine, Vol. 2, Iss. 6, 2011-01 ,pp. : 1097-1103

Spandidos Publications

Access to resources Recommend Favorite

Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer

By Bao Philip   Ramanathan Ramesh   Krasinkas Alyssa   Bahary Nathan   Lembersky Barry   Bartlett David   Hughes Steven   Lee Kenneth   Moser A.   Zeh Herbert  

Annals of Surgical Oncology, Vol. 18, Iss. 4, 2011-04 ,pp. : 1122-1129

Springer Publishing Company

Access to resources Recommend Favorite

Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 174-179

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of Glucose Transporter-1, Hexokinase-II, Proliferating Cell Nuclear Antigen and Survival of Patients with Pancreatic Cancer

By Lyshchik Andrej   Higashi Tatsuya   Hara Tadashi   Nakamoto Yuji   Fujimoto Koji   Doi Ryuichiro   Imamura Masayuki   Saga Tsuneo   Togashi Kaori  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 154-162

Informa Healthcare

Access to resources Recommend Favorite